Evidence for a preferential loss of enkephalin immunoreactivity in the external globus pallidus in low grade Huntington's disease using high resolution image analysis
- 1 January 1995
- journal article
- research article
- Published by Elsevier in Neuroscience
- Vol. 64 (2) , 397-404
- https://doi.org/10.1016/0306-4522(94)00427-7
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Huntington's disease gene (IT15) is widely expressed in human and rat tissuesNeuron, 1993
- Loss of cannabinoid receptors in the substantia nigra in huntington's diseaseNeuroscience, 1993
- A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomesCell, 1993
- Nigral dopamine type-1 receptors are reduced in Huntington's disease: A postmortem autoradiographic study using [3H]SCH 23390 and correlation with [3H]forskolin bindingExperimental Neurology, 1990
- Evidence for Degenerative and Regenerative Changes in Neostriatal Spiny Neurons in Huntington's DiseaseScience, 1985
- Immunocytochemical Studies of Substance P and Met-Enkephalin in the Basal Ganglia and Substantia Nigra in Huntingtonʼs, Parkinsonʼs and Alzheimerʼs DiseasesJournal of Neuropathology and Experimental Neurology, 1985
- Immunocytochemical studies of substance P and leucine-enkephalin in Huntington's diseaseBrain Research, 1983
- Ramifications of the globus pallidus in the rat as indicated by patterns of immunohistochemistryNeuroscience, 1983
- Correlation between met-enkephalin and substance P immunoreactivity in the primate globus pallidusNeuroscience, 1981
- Regional distribution of methionine-enkephalin and substance P-like immunoreactivity in normal human brain and in Huntington's diseaseBrain Research, 1980